Your browser doesn't support javascript.
loading
The Infant KIdney Dialysis and Utrafiltration (I-KID) Study: A Stepped-Wedge Cluster-Randomized Study in Infants, Comparing Peritoneal Dialysis, Continuous Venovenous Hemofiltration, and Newcastle Infant Dialysis Ultrafiltration System, a Novel Infant Hemodialysis Device.
Lambert, Heather; Hiu, Shaun; Coulthard, Malcolm G; Matthews, John N S; Holstein, Eva-Maria; Crosier, Jean; Agbeko, Rachel; Brick, Thomas; Duncan, Heather; Grant, David; Mok, Quen; Nyman, Andrew Gustaf; Pappachan, John; Boucher, Chris; Bulmer, Joe; Chisholm, Denise; Cromie, Kirsten; Emmet, Victoria; Feltbower, Richard G; Ghose, Arunoday; Grayling, Michael; Harrison, Rebecca; Kennedy, Ciara A; McColl, Elaine; Morris, Kevin; Norman, Lee; Office, Julie; Parslow, Roger; Pattinson, Christine; Sharma, Shriya; Smith, Jonathan; Steel, Alison; Steel, Rachel; Straker, Jayne; Vrana, Lamprini; Walker, Jenn; Wellman, Paul; Whitaker, Mike; Wightman, Jim; Wilson, Nina; Wirz, Lucy; Wood, Ruth.
Afiliación
  • Lambert H; Paediatric Nephrology Department, Great North Children's Hospital, Royal Victoria Infirmary, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
  • Hiu S; Biostatistics Research Group, Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom.
  • Coulthard MG; Paediatric Nephrology Department, Great North Children's Hospital, Royal Victoria Infirmary, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
  • Matthews JNS; Biostatistics Research Group, Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom.
  • Holstein EM; School of Mathematics, Statistics & Physics, Newcastle University, Newcastle Upon Tyne, United Kingdom.
  • Crosier J; Newcastle Clinical Trials Unit, Newcastle University, Newcastle Upon Tyne, United Kingdom.
  • Agbeko R; Paediatric Nephrology Department, Great North Children's Hospital, Royal Victoria Infirmary, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
  • Brick T; Paediatric Nephrology Department, Great North Children's Hospital, Royal Victoria Infirmary, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
  • Duncan H; Cardiac Intensive Care Unit, Great Ormond Street Hospital NHS Trust, London, United Kingdom.
  • Grant D; Department of Paediatric Intensive Care, Birmingham Women's and Children's Hospital, Birmingham, United Kingdom.
  • Mok Q; Paediatric Intensive Care Unit, Bristol Royal Hospital for Children and University of Bristol Medical School, Bristol, United Kingdom.
  • Nyman AG; Paediatric Intensive Care Unit, Great Ormond Street Hospital for Children, London, United Kingdom.
  • Pappachan J; Paediatric Intensive Care Unit, Evelina London Children's Hospital, London, United Kingdom.
  • Boucher C; Paediatric Intensive Care Unit, Southampton Children's Hospital, Southampton NIHR Biomedical Centre, Southampton, United Kingdom.
  • Bulmer J; Parent, Antrim, Northern Ireland, United Kingdom.
  • Chisholm D; Northern Medical Physics and Clinical Engineering, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom.
  • Cromie K; Paediatric Nephrology Department, Great North Children's Hospital, Royal Victoria Infirmary, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
  • Emmet V; Leeds Institute for Data Analytics, School of Medicine, Leeds, United Kingdom.
  • Feltbower RG; Clinical Resource Building, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom.
  • Ghose A; Clinical Resource Building, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom.
  • Grayling M; Department of Paediatric Intensive Care, Birmingham Women's and Children's Hospital, Birmingham, United Kingdom.
  • Harrison R; Biostatistics Research Group, Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom.
  • Kennedy CA; Northern Medical Physics and Clinical Engineering, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom.
  • McColl E; Newcastle Clinical Trials Unit, Newcastle University, Newcastle Upon Tyne, United Kingdom.
  • Morris K; Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom.
  • Norman L; Department of Paediatric Intensive Care, Birmingham Women's and Children's Hospital, Birmingham, United Kingdom.
  • Office J; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
  • Parslow R; Clinical Resource Building, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom.
  • Pattinson C; Leeds Institute for Data Analytics, School of Medicine, Leeds, United Kingdom.
  • Sharma S; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, Leeds, United Kingdom.
  • Smith J; Leeds Institute for Data Analytics, School of Medicine, Leeds, United Kingdom.
  • Steel A; Newcastle Clinical Trials Unit, Newcastle University, Newcastle Upon Tyne, United Kingdom.
  • Steel R; Paediatric Intensive Care Unit, Freeman Hospital, Newcastle Upon Tyne NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
  • Straker J; Newcastle Clinical Trials Unit, Newcastle University, Newcastle Upon Tyne, United Kingdom.
  • Vrana L; Leeds Institute for Data Analytics, School of Medicine, Leeds, United Kingdom.
  • Walker J; Leeds Institute for Data Analytics, School of Medicine, Leeds, United Kingdom.
  • Wellman P; Paediatric Intensive Care Unit, Freeman Hospital, Newcastle Upon Tyne NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
  • Whitaker M; Newcastle Clinical Trials Unit, Newcastle University, Newcastle Upon Tyne, United Kingdom.
  • Wightman J; Paediatric Intensive Care Unit, Evelina London Children's Hospital, London, United Kingdom.
  • Wilson N; Northern Medical Physics and Clinical Engineering, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom.
  • Wirz L; Northern Medical Physics and Clinical Engineering, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom.
  • Wood R; Biostatistics Research Group, Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom.
Pediatr Crit Care Med ; 24(7): 604-613, 2023 Jul 01.
Article en En | MEDLINE | ID: mdl-36892305
ABSTRACT

OBJECTIVES:

Renal replacement therapy (RRT) options are limited for small babies because of lack of available technology. We investigated the precision of ultrafiltration, biochemical clearances, clinical efficacy, outcomes, and safety profile for a novel non-Conformité Européenne-marked hemodialysis device for babies under 8 kg, the Newcastle Infant Dialysis Ultrafiltration System (NIDUS), compared with the current options of peritoneal dialysis (PD) or continuous venovenous hemofiltration (CVVH).

DESIGN:

Nonblinded cluster-randomized cross-sectional stepped-wedge design with four periods, three sequences, and two clusters per sequence.

SETTING:

Clusters were six U.K. PICUs. PATIENTS Babies less than 8 kg requiring RRT for fluid overload or biochemical disturbance.

INTERVENTIONS:

In controls, RRT was delivered by PD or CVVH, and in interventions, NIDUS was used. The primary outcome was precision of ultrafiltration compared with prescription; secondary outcomes included biochemical clearances. MEASUREMENTS AND MAIN

RESULTS:

At closure, 97 participants were recruited from the six PICUs (62 control and 35 intervention). The primary outcome, obtained from 62 control and 21 intervention patients, showed that ultrafiltration with NIDUS was closer to that prescribed than with control sd controls, 18.75, intervention, 2.95 (mL/hr); adjusted ratio, 0.13; 95% CI, 0.03-0.71; p = 0.018. Creatinine clearance was smallest and least variable for PD (mean, sd ) = (0.08, 0.03) mL/min/kg, larger for NIDUS (0.46, 0.30), and largest for CVVH (1.20, 0.72). Adverse events were reported in all groups. In this critically ill population with multiple organ failure, mortality was lowest for PD and highest for CVVH, with NIDUS in between.

CONCLUSIONS:

NIDUS delivers accurate, controllable fluid removal and adequate clearances, indicating that it has important potential alongside other modalities for infant RRT.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hemofiltración / Diálisis Peritoneal / Lesión Renal Aguda / Terapia de Reemplazo Renal Continuo Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans / Infant Idioma: En Revista: Pediatr Crit Care Med Asunto de la revista: PEDIATRIA / TERAPIA INTENSIVA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hemofiltración / Diálisis Peritoneal / Lesión Renal Aguda / Terapia de Reemplazo Renal Continuo Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans / Infant Idioma: En Revista: Pediatr Crit Care Med Asunto de la revista: PEDIATRIA / TERAPIA INTENSIVA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido